Skip to main content
. 2012 Nov 15;12:105. doi: 10.1186/1471-2261-12-105

Table 7.

Comparisons of HRV measurement in the group of patients with and without LVH

 
Patients with LVH
Patients without LVH
P values
 
Mean
St. Dev.
Quartiles
Mean
St. Dev.
Quartiles
 
      1st 2nd 3rd     1st 2nd 3rd  
AVNN
846.9
121.8
772.6
829.5
916.8
883.1
129.2
789.9
863.7
963.8
0.071
SDNN
123.5
37.0
101.5
118.3
142.3
118.4
36.0
91.8
112.7
142.4
0.247
SDANN
111.2
37.6
88.0
106.7
128.7
105.9
36.3
79.4
99.0
129.5
0.304
SDNN IDX
51.9
15.0
42.7
49.5
60.8
49.5
15.2
38.5
47.8
58.4
0.127
RMSSD
32.8
14.5
22.9
29.2
36.4
36.4
18.1
23.1
32.4
42.3
0.123
pNN50
9.9
10.3
3.2
7.1
11.9
11.2
9.4
3.4
9.2
17.0
0.163
TOTPWR
18472
12108
10873
15952
21928
17029
10776
8958
14057
22697
0.288
ULF
15018
10082
8177
12029
18491
13872
9043
7093
11412
18656
0.347
VLF
1892
1255
1074
1668
2393
1697
1206
923
1336
2086
0.105
LF
896
782
429
704
1092
744
619
369
556
912
0.072
HF
666
694
210
483
757
716
622
261
502
965
0.316
LF/HF 1.74 0.99 1.03 1.60 2.08 1.28 0.74 0.81 1.03 1.51 <0.001

St. Dev. standard deviation.

The p-values refer to Wilcoxon test.